SELLAS Life Sciences Group, Inc.SLSNASDAQ
LOADING
|||
Operating Income Contraction
Trending higher, below historical average.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-31.51M
↓ 16% below average
Average (9y)
$-27.12M
Historical baseline
Range
High:$-15.71M
Low:$-41.95M
CAGR
-0.9%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-31.51M | +16.8% |
| 2023 | $-37.87M | +9.7% |
| 2022 | $-41.95M | -65.8% |
| 2021 | $-25.29M | -48.9% |
| 2020 | $-16.98M | +15.3% |
| 2019 | $-20.04M | +36.6% |
| 2018 | $-31.59M | -101.0% |
| 2017 | $-15.71M | +1.7% |
| 2016 | $-15.99M | +53.3% |
| 2015 | $-34.22M | - |